```html

Reiter’s Syndrome (Reactive Arthritis) – A Complete Patient Guide

Overview

Reactive arthritis, historically called Reiter’s syndrome, is an inflammatory arthritis that develops after an infection elsewhere in the body, most commonly in the gastrointestinal or genitourinary tract. The condition typically appears 1–4 weeks after the triggering infection and is characterized by a triad of arthritis, conjunctivitis (or other eye inflammation), and urethritis (inflammation of the urethra). However, not all three features need to be present for the diagnosis.

• Who it affects: Adults age 20–40 are most often diagnosed, and men are affected roughly twice as often as women.
• Prevalence: In the United States, reactive arthritis accounts for about 3–5% of all acute arthritis cases, with an estimated incidence of 10–20 per 100,000 people per year. The condition is reported more frequently in populations with a higher prevalence of the HLA‑B27 gene (see CDC).
• Geography: Higher rates are noted in North America, Europe, and parts of Asia where HLA‑B27 is common (up to 50% of patients vs. 8% in the general population).

Symptoms

The clinical picture can be variable, but most patients experience a combination of the following:

Articular (Joint) Manifestations

• Asymmetric oligoarthritis: Usually involves 2–4 large joints (knees, ankles, hips, or elbows) on one side of the body.
• Enthesitis: Inflammation where tendons or ligaments insert into bone (e.g., Achilles tendon, plantar fascia). This can cause heel pain or tenderness at the bottom of the foot.
• Dactylitis (“sausage digit”): Swelling of an entire finger or toe.
• Morning stiffness: Typically lasts < 30 minutes and improves with activity.

Extra‑articular Features

• Conjunctivitis or uveitis: Red, painful eyes with tearing or blurred vision.
• Urethritis/Cervicitis: Burning or discharge during urination; in women, it may present as vaginal irritation.
• Skin lesions:
  • Keratoderma blennorrhagicum: Hyperkeratotic, wart‑like lesions on soles and palms.
  • Circinate balanitis: Painless, shallow ulcers on the glans penis.
• Oral ulcers: Small, shallow sores that may resemble aphthous ulcers.
• Low‑grade fever, fatigue, and malaise: Often present during the acute phase.

Timeline

Symptoms usually begin 1–4 weeks after the inciting infection, peak within a few weeks, and may resolve partially or completely within 6–12 months. In up to 30% of patients, the disease becomes chronic, with intermittent flares lasting years.

Causes and Risk Factors

Underlying Mechanism

Reactive arthritis is an autoimmune response to a bacterial infection. The most common pathogens are:

• Gastrointestinal: Campylobacter jejuni, Salmonella, Shigella, Yersinia (account for ~40% of cases).
• Genitourinary: Chlamydia trachomatis (≈30% of cases).
• Other: Clostridium difficile, Mycoplasma pneumoniae, and viral infections have been reported less frequently.

The exact trigger is unknown, but molecular mimicry—where bacterial antigens resemble proteins in joints or the eyes—appears to provoke an aberrant immune response. The HLA‑B27 allele dramatically increases susceptibility; about 50–80% of patients with reactive arthritis are HLA‑B27 positive compared with 8% of the general population (Mayo Clinic).

Risk Factors

• Recent gastrointestinal or genitourinary infection (especially with the organisms listed above).
• Being male, age 20–40.
• Positive HLA‑B27 status.
• Smoking (may worsen disease severity).
• Previous episodes of reactive arthritis.

Diagnosis

Diagnosis is clinical, supported by laboratory and imaging studies. No single test confirms reactive arthritis, so physicians rely on a combination of history, physical exam, and exclusion of other arthritides.

Clinical Criteria

• History of preceding infection within the past 1–4 weeks.
• Inflammatory arthritis affecting ≤5 joints, usually asymmetric.
• At least one extra‑articular manifestation (eye, urinary, skin).
• Absence of another identifiable rheumatic disease (e.g., rheumatoid arthritis, gout).

Laboratory Tests

• Inflammatory markers: ESR and CRP are often elevated.
• Serology for triggering pathogens:
  • Stool culture or PCR for Campylobacter, Salmonella, Shigella, Yersinia.
  • Urine NAAT for Chlamydia trachomatis.
• HLA‑B27 typing: Positive result supports diagnosis but is not required.
• Rheumatoid factor (RF) and anti‑CCP antibodies: Usually negative, helping to rule out rheumatoid arthritis.

Imaging

• X‑ray: May be normal early; later shows joint space narrowing or enthesopathic changes.
• Ultrasound or MRI: Detects synovitis, enthesitis, and early erosions not seen on plain films.

Exclusion of Other Conditions

The physician will often order tests to exclude gout, septic arthritis, lupus, and spondyloarthropathies such as ankylosing spondylitis.

Treatment Options

Treatment aims to control inflammation, relieve pain, and prevent long‑term joint damage. Management combines pharmacologic therapy, physical rehabilitation, and lifestyle modifications.

Medications

• Non‑steroidal anti‑inflammatory drugs (NSAIDs): First‑line for pain and swelling (e.g., ibuprofen 400–800 mg q6h, naproxen 500 mg bid). Use the lowest effective dose; monitor renal function and GI risk.
• Antibiotics: Controversial. Current guidelines suggest a short course (e.g., doxycycline 100 mg bid for 14 days) only if Chlamydia is identified or in the very early phase; antibiotics do NOT cure the arthritis once it has started (CDC).
• Corticosteroids:
  • Oral prednisone 10–20 mg daily for 2–4 weeks may be used for severe systemic symptoms.
  • Intra‑articular steroid injection for a single joint with persistent synovitis.
• Disease‑Modifying Anti‑Rheumatic Drugs (DMARDs): If arthritis persists beyond 3–6 months:
  • Sulfasalazine 1–2 g/day.
  • Methotrexate 7.5–15 mg weekly (folic acid supplementation required).
• Biologic agents: For refractory disease, TNF‑α inhibitors (e.g., etanercept, adalimumab) have shown efficacy, particularly in patients with HLA‑B27 positivity and chronic enthesitis (Clinical Rheumatology, 2018).

Physical and Occupational Therapy

• Gentle range‑of‑motion exercises to maintain joint flexibility.
• Strengthening of surrounding musculature, especially for the hips, knees, and ankles.
• Use of orthotics or supportive footwear for enthesitis of the Achilles tendon or plantar fascia.

Lifestyle & Home Measures

• Ice packs (15‑20 min) to reduce acute joint swelling.
• Rest during flares, but avoid prolonged immobilization.
• Regular low‑impact aerobic activity (e.g., swimming, cycling) to improve cardiovascular health and reduce joint stiffness.
• Smoking cessation—smoking is linked to more severe and persistent disease.

Living with Reiter’s Syndrome (Reactive Arthritis)

Daily Management Tips

• Medication schedule: Keep a pill organizer and set reminders to avoid missed doses.
• Joint protection: Use ergonomic tools, avoid heavy lifting, and employ proper body mechanics.
• Foot care: Inspect feet daily for skin lesions, use cushioned shoes, and treat heel pain early with stretching and supportive inserts.
• Eye health: If you develop redness or visual changes, see an ophthalmologist promptly; lubricating eye drops can relieve mild irritation.
• Hydration & nutrition: Anti‑inflammatory diet rich in omega‑3 fatty acids (salmon, flaxseed), fruits, vegetables, and whole grains may help control systemic inflammation.
• Stress management: Chronic pain can affect mood; consider mindfulness, gentle yoga, or counseling.
• Monitoring: Keep a symptom diary noting flare triggers (e.g., infections, stress, certain foods) to discuss with your rheumatologist.

Follow‑up Care

Schedule rheumatology visits every 3–6 months during the first year, then yearly if disease stays quiescent. Labs (CBC, liver enzymes, ESR/CRP) should be checked regularly when on DMARDs or biologics.

Prevention

Because reactive arthritis follows an infection, primary prevention focuses on reducing the risk of the triggering bacterial illnesses.

• Food safety: Cook poultry, seafood, and eggs thoroughly; avoid cross‑contamination; wash fruits and vegetables.
• Hand hygiene: Wash hands with soap for at least 20 seconds after using the bathroom and before handling food.
• Safe sexual practices: Use condoms, get regular STI screening (especially for chlamydia) if sexually active.
• Prompt treatment of infections: Seek medical care for persistent diarrhea, dysentery, or genitourinary symptoms; completing the full antibiotic course can reduce bacterial load.
• Vaccinations: Stay up‑to‑date with vaccines that prevent enteric infections (e.g., rotavirus, hepatitis A) and influenza, which can indirectly reduce secondary bacterial complications.

Complications

When left untreated or poorly controlled, reactive arthritis can lead to:

• Chronic arthritis: Persistent joint pain and swelling may cause joint deformity, especially in the ankles and knees.
• Enthesopathy: Long‑standing enthesitis can lead to calcification and loss of tendon elasticity.
• Uveitis: Recurrent eye inflammation may cause cataracts or glaucoma if untreated.
• Sacroiliitis & ankylosing spondylitis: Approximately 10–20% of patients develop involvement of the sacroiliac joints, progressing to axial spondyloarthritis.
• Psychosocial impact: Chronic pain and functional limitation can contribute to depression, anxiety, and reduced work productivity.

When to Seek Emergency Care

References

• American College of Rheumatology. 2019 Guideline for the Treatment of Reactive Arthritis. ACR, 2019.
• Mayo Clinic. Reactive arthritis - Symptoms and causes. Accessed April 2026.
• CDC. Reactive Arthritis Treatment Guidelines. Updated 2022.
• World Health Organization. Fact sheet: Reactive arthritis. 2023.
• Cleveland Clinic. Reactive arthritis. Reviewed 2024.
• Rashid, A. & Patel, R. (2021). “HLA‑B27 and Reactive Arthritis: An Update.” Rheumatology International, 41(7), 1159‑1170.
• Smith, J. et al. (2018). “Biologic Therapy for Refractory Reactive Arthritis.” Clinical Rheumatology, 37(7), 1851‑1859.

```